Olaparib

Olaparib is a targeted cancer treatment known as a PARP inhibitor. It works by blocking a specific enzyme involved in repairing damaged DNA within cells. Cancer cells often rely heavily on this repair process to survive, especially when they already have other genetic mutations. By inhibiting PARP enzymes, Olaparib causes cancer cells with certain genetic flaws—like BRCA mutations—to accumulate irreversible DNA damage, leading to their death. It is primarily used to treat specific types of cancers, including ovarian, breast, and prostate cancers, especially in patients with those genetic mutations, offering a more personalized approach to cancer therapy.